Gene Query: CCDC115

Dataset Description Geneva Score
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 57.88
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 22.68
Generation and functional characterization of MDSC-like cells 17.3
The comparison of high-throughput single-cell RNA-seq methods 16.45
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 12.9
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 11.37
In situ CAPTURE of chromatin interactions by biotinylated dCas9 9.76
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 9.76
Comprehensive comparative analysis of 5’ end RNA sequencing methods 9.73
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 9.45
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 9.45
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 9.25
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 8.73
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 7.82
RNA-seq of young and quiescent MRC-5 human fibroblasts 7.79
Stem and effector CD8 T-cells from human cancers 6.97
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 6.8
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 6.77
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 6.77
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 6.72
Transcriptional changes in lymphoma cells induced by LSD1 depletion 6.72
Macrophage Ad5f35 PhenoMap 6.67
Pharmacologic inhibition of STAT5 in AML 6.64
MeRIP-seq for heat shock in B-cell lymphoma cells 6.57
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 6.45
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 6.45
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 6.34
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 6.28
Integrating single-cell transcriptomic data across different conditions, technologies, and species 6.27
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 6.25
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 6.16
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 6.13
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 6.03
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 5.77
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 5.67
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 5.54
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 5.42
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 5.38
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 5.22
Spliceosomal disruption of the non-canonical BAF complex in cancer 5.2
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 5.2
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 5.13
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 5.05
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 4.97
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 4.82
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 4.81
Electronic cigarettes 4.6
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 4.47
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 4.42
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 4.4
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 4.38
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 4.35
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 4.35
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 4.34
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 4.31
Generating Patterned Kidney Organoids for Studying Development and Diseases 4.29
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 4.27
CROP-Seq in Primary Human T Cells 4.25
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 4.22
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 4.19
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 4.16
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 4.13
Gene expression signatures of innate lymphoid cells from human blood 4.11
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 4.0
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 3.95
Identification of renal resident macrophages across species 3.9
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 3.89
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 3.88
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 3.88
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 3.87
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 3.82
LncRNA expression profiling of ischemic stroke patients 3.77
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 3.74
Accurate annotation of human protein-coding small open reading frames 3.73
Transcriptome of diurnal human blood neutrophils 3.71
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 3.63
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 3.58
The landscape of alternative splicing in aggressive prostate cancers 3.56
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 3.55
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 3.52
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 3.52
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 3.49
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 3.47
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 3.47
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 3.47
TOP2B disturbed the quality of human oocytes with advanced maternal age 3.44
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 3.42
Conservative alteration of chromosomal expression pattern across human solid tumor types 3.41
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 3.39
Generation and persistence of human tissue-resident memory T cells in lung transplantation 3.38
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 3.34
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 3.34
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 3.34
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 3.34
RNAseq Analysis in glioblastoma cells treated with Mepazine 3.31
DART-seq: an antibody-free method for global m6A detection 3.28
Transcriptome sequencing of K-562 cells 3.22
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 3.21
Characterization of human ILC2 subsets 3.21
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 3.2
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 3.18
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 3.18
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 3.13
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 3.12
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 3.12
Single-cell analysis of adult human ovary using 10X genomics 3.08
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.06
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.06
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 3.04
Transcriptome of activated human and mouse MAIT cells 3.02
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 3.0
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 2.99
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 2.96
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 2.95
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 2.95
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 2.92
Proteomics identifies a marker signature of MAPKi resistance in melanoma 2.87
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 2.86
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 2.86
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 2.81
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 2.8
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 2.76
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 2.75
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 2.73
Regulating Interleukin-2 activity with engineered receptor signaling clamps 2.72
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 2.72
Tumor exosome integrins determine organotropic metastasis 2.72
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 2.71
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 2.69
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 2.68
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 2.65
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 2.65
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 2.64
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 2.63
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 2.63
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 2.61
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 2.6
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 2.6
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 2.6
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 2.58
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 2.58
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 2.56
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 2.56
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 2.56
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 2.56
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 2.56
Seletive inhibition of CDK9 in DLBCL cell lines 2.56
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 2.54
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 2.53
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 2.53
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 2.52
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 2.51
RNA sequencing of primary human platelets and in vitro cell lines 2.48
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 2.48
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 2.48
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 2.48
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 2.48
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 2.47
CD73 knockdown effect in pancreatic cancer cell lines 2.45
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 2.44
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 2.44
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 2.44
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 2.44
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 2.42
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 2.42
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 2.4
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 2.37
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 2.37
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 2.37
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 2.35
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 2.34
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 2.34
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 2.33
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 2.3
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 2.27
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 2.27
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 2.27
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 2.25
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 2.25
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 2.24
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 2.24
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 2.23
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 2.2
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 2.2
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 2.2
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 2.2
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 2.2
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 2.19
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 2.19
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 2.18
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 2.18
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 2.18
Transciptomic profiling of human fetal lung samples 2.18
Silencing SPIB in attached and floating state of H1703 lung cancer cells 2.18
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 2.17
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 2.15
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 2.15
RNA-seq analysis of the human fetal kidney. 2.14
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 2.14
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 2.13
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 2.12
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 2.12
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 2.12
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 2.12
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 2.11
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 2.11
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 2.1
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 2.09
The effect of insulin on mRNA transcription of human pluripotent stem cells 2.08
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 2.05
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 2.05
Transcriptional profiling of microglia; current state of the art and future perspectives 2.04
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 2.04
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 2.03
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 2.03
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 2.02
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 2.01
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 2.01
mRNA expression profile of Lymphocytes by high-throuput sequencing 2.0
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 2.0
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 1.99
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 1.99
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 1.99
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 1.98
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 1.98
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 1.96
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 1.96
Transcriptomic analysis of human tonsillar TFH subsets 1.95
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 1.95
H1609088 Human RNA-Sequencing 1.94
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 1.94
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 1.93
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 1.93
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 1.92
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 1.89
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 1.89
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 1.88
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 1.88
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 1.87
mRNA sequencing analysis of cultured human primary airway epithelial cells upon exposure to PMN exosomes 1.87
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 1.85
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 1.84
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 1.84
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 1.82
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 1.81
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 1.81
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 1.81
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 1.81
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 1.79
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 1.79
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 1.78
PRDM1 inhibits proliferation of human colon cancer organoids 1.78
Genome-wide discovery of human splicing branchpoints [RNAse] 1.77
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 1.77
RNA-Seq and expression data from human adipose tissue 1.77
Comparing gene expression in iPSC derived RPE from control and AMD donors 1.75
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 1.73
RNA-seq of Single-Cell Genotyping of Transcriptomes 1.72
Single-Cell Genotyping of Transcriptomes 1.72
Dysregulated immune system networks in war veterans with PTSD 1.71
BACH2 in human plasma cell fate decision 1.71
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 1.71
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 1.71
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 1.7
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 1.7
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 1.69
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 1.68
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 1.64
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 1.64
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 1.64
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 1.63
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 1.63
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 1.63
The Human Testis Cell Atlas via Single-cell RNA-seq 1.63
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 1.59
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 1.57
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 1.56
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 1.56
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 1.55
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 1.53
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 1.52
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 1.52
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 1.51
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 1.49
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 1.49
NR2F2 study 1.49
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 1.47
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 1.47
Identification of a LIF-responsive replication-competent human β cell 1.45
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 1.43
RNA-seq differential expression studies: more sequence, or more replication? 1.4
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 1.4
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 1.37
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 1.36
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 1.36
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 1.36
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 1.34
K562 polyA RNA-Seq 1.34
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 1.33
Be1 and Be2 B cells are transcriptionally distinct 1.33
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 1.32
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 1.3
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 1.3
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 1.29
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 1.28
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 1.27
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 1.26
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 1.26
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 1.25
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 1.25
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 1.24
Human Treg NaCl stimulation 1.24
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 1.23
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 1.23
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 1.23
Identification of renal resident macrophages across species [C1] 1.22
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 1.22
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 1.22
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 1.2
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 1.18
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 1.16
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 1.16
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 1.16
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 1.15
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 1.15
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 1.15
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 1.14
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 1.14
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 1.13
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 1.1
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 1.1
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 1.1
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 1.07
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 1.06
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 1.06
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 1.03
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 1.01
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 0.99
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 0.98
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 0.98
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 0.98
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 0.97
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 0.95
Energy Metabolism during Anchorage-Independence 0.94
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 0.94
RNA editing in nascent RNA affects pre-mRNA splicing 0.93
Transcriptional profile in human S. haematobium infection 0.93
Trans-differentiation of human adult peripheral blood T cells into neurons 0.93
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.93
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.92
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 0.92
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 0.92
Single-cell analysis of human kidney organoids 0.91
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 0.9
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 0.89
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 0.89
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 0.87
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 0.86
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 0.86
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 0.86
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.85
Expression analysis of the TAF1 syndrome 0.85
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 0.85
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 0.84
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.84
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 0.84
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 0.82
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 0.79
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 0.78
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 0.77
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.76
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 0.75
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 0.75
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 0.75
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.75
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 0.74
RNA sequencing of matched nephrectomy samples [RNA-seq] 0.74
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.74
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.73
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.71
nELAVL HITS-CLIP in Alzheimer's Disease patients 0.71
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 0.71
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 0.7
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 0.69
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 0.69
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.68
miRNAs affected by antagomiR-17 treatment 0.67
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.67
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.67
Functional significance of the HIV-1 Tat signature amino acid residues 0.66
RNAseq of cell lines with knocked in ESR1 mutations 0.65
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 0.62
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 0.62
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 0.62
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.61
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 0.59
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 0.59
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 0.59
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.57
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 0.53
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.52
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 0.52
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.52
Microglia innatly develop within cerebral organoids 0.51
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.51
High-throughput sequencing of pluripotent cells 0.51
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 0.5
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 0.49
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 0.49
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.48
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.47
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 0.47
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 0.47
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 0.46
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 0.45
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.45
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.45
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 0.44
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.41
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.41
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 0.39
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 0.38
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.37
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 0.36
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 0.36
Effect of BMP inhibition or stimulation of primary human keratinocytes 0.35
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 0.35
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.34
U2AF1 mutations alter splice site recognition in hematological malignancies 0.34
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 0.32
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.3
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 0.29
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 0.29
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 0.29
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 0.28
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 0.27
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 0.27
Discovering human diabetes-risk gene function with genetics and physiological assays 0.27
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 0.27
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 0.27
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 0.27
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.27
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.25
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.25
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.25
Oncogenic roles of ARID5B in T-ALL 0.23
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.23
Measure transcript integrity using RNA-seq data 0.23
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 0.22
Preclinical model of obesity and ER-positive breast cancer 0.22
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 0.22
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 0.21
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.21
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 0.2
Genome-wide discovery of human splicing branchpoints 0.19
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.18
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 0.18
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 0.18
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.17
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 0.17
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 0.16
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 0.16
Transcriptome wide analysis of classically and alternatively activated macrophages 0.15
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.14
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 0.14
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.14
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 0.13
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 0.13
Transcriptomic analysis of human macrophages in 3D 0.12
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.12
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.11
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.1
Single cell transcriptome of peritoneal cells 0.08
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 0.08
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 0.07
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.07
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.06
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.06
Dermal endothelial cells of type 2 diabetic patients 0.06
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 0.05
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 0.04
quanTIseq: quantifying immune contexture of human tumors 0.04
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 0.04
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 0.03
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 0.03
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 0.03
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 0.03
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.03
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.03
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.03
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.02
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 0.01
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 0.01
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 0.01
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.01
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.01
O-glcnAc reprograms cellular energetics 0.0
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.0
Specific molecular signatures underlie response to decitabine in CMML 0.0
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation